Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 4
2006 5
2007 8
2008 11
2009 16
2010 38
2011 26
2012 35
2013 38
2014 26
2015 9
2016 3
2017 3
2018 3
2019 5
2020 2
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 20671223

202 results
Results by year
Filters applied: . Clear all
Page 1
Rituximab treatment for vasculitis.
Jayne D. Jayne D. Clin J Am Soc Nephrol. 2010 Aug;5(8):1359-62. doi: 10.2215/CJN.05500610. Epub 2010 Jul 29. Clin J Am Soc Nephrol. 2010. PMID: 20671223 Free article. No abstract available.
Rituximab as maintenance therapy for anti-neutrophil cytoplasmic antibody-associated vasculitis.
Rhee EP, Laliberte KA, Niles JL. Rhee EP, et al. Clin J Am Soc Nephrol. 2010 Aug;5(8):1394-400. doi: 10.2215/CJN.08821209. Epub 2010 May 24. Clin J Am Soc Nephrol. 2010. PMID: 20498238 Free PMC article.
Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis.
Smith RM, Jones RB, Guerry MJ, Laurino S, Catapano F, Chaudhry A, Smith KG, Jayne DR. Smith RM, et al. Arthritis Rheum. 2012 Nov;64(11):3760-9. doi: 10.1002/art.34583. Arthritis Rheum. 2012. PMID: 22729997 Free article.
[The role of rituximab in the treatment of ANCA-associated systemic vasculitis].
Roccatello D, Vangelista A, Pani A. Roccatello D, et al. G Ital Nefrol. 2011 Sep-Oct;28(5):474-88. G Ital Nefrol. 2011. PMID: 22028261 Review. Italian.
S2. Rituximab for ANCA-associated vasculitis: the UK experience.
Jayne D. Jayne D. Presse Med. 2013 Apr;42(4 Pt 2):532-4. doi: 10.1016/j.lpm.2013.01.049. Epub 2013 Mar 9. Presse Med. 2013. PMID: 23490639 Review. No abstract available.
Long-term maintenance therapy using rituximab-induced continuous B-cell depletion in patients with ANCA vasculitis.
Pendergraft WF 3rd, Cortazar FB, Wenger J, Murphy AP, Rhee EP, Laliberte KA, Niles JL. Pendergraft WF 3rd, et al. Clin J Am Soc Nephrol. 2014 Apr;9(4):736-44. doi: 10.2215/CJN.07340713. Epub 2014 Mar 13. Clin J Am Soc Nephrol. 2014. PMID: 24626432 Free PMC article.
Off-trial evaluation of the B cell-targeting treatment in the refractory cases of antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: long-term follow-up from a single centre.
Pullerits R, Ljevak M, Vikgren J, Bokarewa M. Pullerits R, et al. Scand J Immunol. 2012 Oct;76(4):411-20. doi: 10.1111/j.1365-3083.2012.02747.x. Scand J Immunol. 2012. PMID: 22823472 Free article.
Rituximab for rescue and maintenance therapy in rapidly progressive life-threatening antineutrophil cytoplasmic autoantibody-associated systemic vasculitis.
José RJ, Chrysochou C, Shurrab AE, New D, Wood GN. José RJ, et al. Scand J Urol Nephrol. 2010 Dec;44(6):459-62. doi: 10.3109/00365599.2010.504193. Epub 2010 Jul 20. Scand J Urol Nephrol. 2010. PMID: 20645677
Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.
Stasi R, Stipa E, Del Poeta G, Amadori S, Newland AC, Provan D. Stasi R, et al. Rheumatology (Oxford). 2006 Nov;45(11):1432-6. doi: 10.1093/rheumatology/kel098. Epub 2006 Apr 21. Rheumatology (Oxford). 2006. PMID: 16632482 Clinical Trial.
[Severe Wegener's granulomatosis successfully treated with rituximab].
Semenkova EN, Krivosheev OG, Novikov PI, Osipenko VI, Nosova NR, Parfenova SA, Nikiforova NV, Borodin OO. Semenkova EN, et al. Ter Arkh. 2010;82(6):53-5. Ter Arkh. 2010. PMID: 20731113 Russian.
202 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback